CASE STUDY: Trumpologia (41) - Coisas que a narrativa esquerdóide sobre a trumpologia não permite compreender

Mais trumpologia.

«Trump Forces Big Pharma to Swallow a Bitter Pill 

The president has been tougher on drug companies than Barack Obama on an issue that animates voters of all political stripes.

(...) Trump’s drug politics, particularly around pricing and opioid abuse, remain attractive two years after his election. As Erickson stated, the Food and Drug Administration under Trump has approved more generic drugs than ever before, clearing a record 971 during fiscal year 2018.

The president also signed two bills in October designed to prevent “gag order” agreements prohibiting pharmacists from helping patients find lower-cost alternatives to the big-money brands. Those brands, in turn, argue that the billions it costs them to develop new pharmaceuticals should grant them a monopoly on those cures once they are brought to market. Since Trump announced a nearly 50-point blueprint to reduce drug costs in early May, there have been fewer brand-name-drug price hikes. An Associated Press investigation found that drug prices on average are still rising, but less dramatically than in the past.»

OZI

Se o Donaldo fez as grandes farmacêuticas engolir uma pílula amarga isso, muito provavelmente, não o livrará de ele próprio ter de engolir a pílula da derrota dos republicanos nas eleições intercalares, perdendo a maioria numa das câmaras, ou na duas.